## ACNB: ACNB Corporation - XLF: Financial Services

### Executive Summary

VALUE thesis: PEG 1.12 indicates fundamental undervaluation. Consistent execution (3/4 quarters beat estimates). Caution: momentum weakening (-2.8% MRS).

- **Horizon:** 20-60 days (position)
- **Risk Profile:** Lower - fundamental undervaluation
- **Stop Type:** Fixed 2xATR ($44.91)
- **If Wrong:** Exit if fundamentals deteriorate or stop hit
- **Invalidation:** PEG > 1.5 or earnings miss

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 14 ($0.14M) |
| Sells | 2 ($0.40M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 30.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 5 |

**Top Holders:**
- FMR, LLC: 5.8% (0.0%)
- Blackrock Inc.: 5.8% (-1.4%)
- Vanguard Group Inc: 5.1% (-1.9%)
- Private Capital Mana: 3.3% (+9.9%)
- Dimensional Fund Adv: 3.0% (+2.7%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-2.8% 5d) with bearish MACD, trend may be turning.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.12 suggests fair value with growth premium. Forward P/E 9.3x stretched relative to 2% growth. Quality metrics strong (margin 24%). Institutional flow bullish (4 buying vs 5 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $0.5B |
| Beta | 0.86 |
| 52W Range | $35.70 - $53.41 |
| Short Interest | 1.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.12 |
| Forward P/E | 9.3 |
| Current P/E | 9.5 |
| YoY Growth | 2.1% |
| EPS Direction | RISING |

### Technicals

MRS_20 deteriorating from -3.0% to -5.8% (-2.8% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 9.8pp (needs >4.0% for momentum thesis). AM_20 at -6.3% indicates price below own 20MA trend. Underperforming sector by 7.0pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.07x) but short-term weakness (below SMA20). MACD histogram bearish (-0.61), momentum weakening. OFD pattern: -SUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -5.75% (CS: 5) | Weak |
| RSI_14 | 34.9 | Neutral |
| MACD Histogram | -0.61 | Bearish |
| vs SMA20 | 0.937x | Below |
| vs SMA50 | 0.979x | Below |
| vs SMA200 | 1.069x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** VALUE

### Trade Setup

- **Entry:** $47.25
- **Stop Loss:** $44.91 (5.0% risk)
- **Target:** $51.93 (R:R method)
- **Risk/Reward:** 2.00:1
- **Target Reasoning:** VALUE thesis targets 2.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 615
- **Position Value:** $29,058.75
- **Portfolio %:** 29.06%
- **Risk Dollars:** $1,440.00
- **Risk Per Trade:** 1.44%
- **Modifiers:** L1 120% | L2 120% | Combined 1.44x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (HIGH) | 1.20x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with stable risk appetite as 2026 trading begins. VIX at 14.51 (4th percentile) signals complacency while positive yield curve (+65bps) and moderate breadth (53.1%) support continuation. Focus on upcoming jobs data (Jan 9) and earnings season kickoff mid-January for directional catalysts.*

### Earnings

**Next:** 2026-01-22 (Est: $1.23)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $1.18 | $1.44 | +21.7% |
| 2025Q2 | $1.15 | $1.25 | +8.8% |
| 2025Q1 | $0.93 | $0.79 | -15.0% |
| 2024Q4 | $0.85 | $0.86 | +0.2% |

---
*RULE-based L3 | 2026-01-06 17:52 | MRS_20*